Workflow
诺思格(301333.SZ)拟推2025年员工持股计划 资金总额不超1500万元
R&G PharmaStudies R&G PharmaStudies (SZ:301333) 智通财经网·2025-09-05 11:25

Core Viewpoint - Norsg (301333.SZ) has disclosed a draft employee stock ownership plan for 2025, with a total funding not exceeding 15 million yuan [1] Group 1: Employee Stock Ownership Plan - The funding for the employee stock ownership plan will come from the company's allocated reward fund and other legally permitted sources [1] - The total stock scale of the employee stock ownership plan is not to exceed 385,800 shares, with the source of the shares being from the company's repurchase special account of A-shares [1] - The purchase price for the repurchased shares is set at 38.88 yuan per share [1] - The duration of the employee stock ownership plan is 36 months, starting from the date of the last transfer of the target shares to the plan [1]